Balance Sheet Details

9 Months Ended

Sep. 30, 2020

Organization Consolidation And Presentation Of Financial Statements [Abstract]

Balance Sheet Details

4. Balance Sheet Details

Property and Equipment, Net

Property and equipment, net as of September 30, 2020 and December 31, 2019 consisted of the following:

	September 30,			December 31,
	2020			2019
	(in thousands)
Furniture and equipment	$	397		$	397
Computers and computer software		169			146
Lab equipment		3,887			3,260
Leasehold improvements		1,903			1,884
Capital leases — lab equipment		—			686
Construction in Progress		14			—
Total property and equipment		6,370			6,373
Less: accumulated depreciation and amortization		(3,831	)		(2,982	)
Property and equipment, net	$	2,539		$	3,391

Depreciation and amortization expense for the three months ended September 30, 2020 and 2019 was $0.3 million and $0.3 million, respectively, of which $0 and $0.1 million related to capital lease amortization expense for the three months ended September 30, 2020 and 2019, respectively. Depreciation and amortization expense for the nine months ended September 30, 2020 and 2019 was $1.1 million and $0.9 million, respectively, of which less than $0.1 million and $0.2 million related to capital lease amortization expense for the nine months ended September 30, 2020 and 2019, respectively.

Accrued Expenses

Accrued expenses as of September 30, 2020 and December 31, 2019 consisted of the following:

	September 30,		December 31,
	2020		2019
	(in thousands)
Preclinical studies	$	1,969	$	844
Professional fees		486		397
Other accrued expenses		415		64
Total	$	2,870	$	1,305